Biotechnology manufacturer
H.R. 6, the "21st Century Cures Act."
Policy issues relating to FDA's "Breakthrough Therapy" designation for pharmaceuticals.
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
FERGUSON STRATEGIES, LLC
801 Pennsylvania Ave NW, Suite 230, Washington, DC, 20004-2697, US
CHRIS JONES ADAM HIGGINS